Diagnostics

Funding Overview

NIAID accepts diagnostics grant applications submitted through two general types of funding opportunities, Investigator-initiated funding opportunities and applications submitted in response to Request for Application (RFA) announcements.

There are a variety of Parent Announcements applicants may use to submit their Investigator-initiated research projects including R01, R03, R21 activity codes, as well as funding opportunities available to Small Businesses (see below). Each Parent Announcement has three receipt dates per year.

In addition to investigator-initiated funding opportunities, NIAID periodically releases Request for Application (RFA) announcements to stimulate targeted research by requesting grant applications in a well-defined scientific area such as diagnostics development. Unlike the Parent Announcements, RFAs have a single receipt date and identify funds set aside and the number of awards likely to be made.

Current Diagnostics Funding Opportunities available to All Research Institutions

There are no active funding opportunities targeted to stimulate infectious disease diagnostics development at this time.

Expired Diagnostics Funding Opportunities that were available to All Research Institutions

These initiatives are no longer active. While new RFAs will not be identical to these expired RFAs, it may be helpful to review these expired RFAs to learn about these types of funding opportunities.

NOTE: If a new RFA announcement is released you must thoroughly read the new announcement and follow all application instructions in the new announcement.

• RFA-AI-09-026 Partnerships for Development of Therapeutics and Diagnostics for Drug-Resistant Bacteria and Eukaryotic Parasites (R01)
• RFA-AI-09-027 Partnerships for Biodefense Food- and Water-borne Diseases (R01)
• RFA-AI-09-028 Partnerships for Biodefense Viral Pathogens (R01)
• RFA-AI-09-034 NIAID Partnerships with Product Development Public-Private Partnerships (R01)

Current Diagnostics Funding Opportunities available to Small Businesses

NIAID also supports diagnostics research conducted by Small Businesses through grants awarded via the following Small Business Technology Transfer (STTR) Funding Opportunities:

• PA-09-080 PHS 2009-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
• PA-09-115 NIAID Advanced Technology SBIR (NIAID-at-SBIR [R43/R44])  This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for advanced technology projects, including diagnostics, that require a longer award period and greater award amount than those routinely allowed under the SBIR program.
• PA-09-081 PHS 2009-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
• PA-09-116 NIAID Advanced Technology STTR (NIAID-at-STTR [R41/R42]) This funding opportunity announcement (FOA) encourages Small Business Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) for advanced technology projects, including diagnostics, that require a longer award period and greater award amount than those routinely allowed under the SBIR program.

If you have general questions regarding any of these diagnostics funding opportunities please contact Dr. Maria Giovanni or Dr. Maureen Beanan.

For a complete list of funding opportunities, please see NIAID Research Funding.

back to top